Interaction of clopidogrel and fufang danshen dripping pills assay in coronary heart disease based on non-target metabolomics.
Guo, Meng-Zhe; Wang, Tian-Yun; Yang, Jian; Chang, Hong; Ji, Shuai; Tang, Dao-Quan.
; 234: 189-196, 2019 Apr 24.
Artigo em Inglês | MEDLINE | ID: mdl-30703494
[Effect of Clopidogrel on Plasma Protein Binding Rates of Ginsenoside Rg1].
[Correlation between CYP2C19 Gene Polymorphism with Clopidogrel Resistance and Distribution of Chinese Medicine Syndrome in 229 Acute Coronary Syndrome Patients].
Continuation versus discontinuation of antiplatelet therapy for bleeding and ischaemic events in adults undergoing non-cardiac surgery.
Real-World Relationship Between Proton Pump Inhibitors and Cerebro-Cardiovascular Outcomes Independent of Clopidogrel.
[Status quo and countermeasure of clopidogrel resistance predicted by gene testing].
Impact of the Chinese herbal medicines on dual antiplatelet therapy with clopidogrel and aspirin: Pharmacokinetics and pharmacodynamics outcomes and related mechanisms in rats.
Assessment of steady-state clopidogrel reactivity by using platelet reactivity units.
Effects of Concurrent Calcium Channel Blocker on Antiplatelet Efficacy of Clopidogrel Therapy: A Systematic Review.
Antiplatelet drug resistance: Molecular insights and clinical implications.
[Differential expression of lncRNA in patients with coronary artery disease plus clopidogrel resistance].